OCRA Orange County Regulatory Affairs Discussion Group. Christine Posin, President June 9, 2008

Similar documents
J. Lawrence Stevens, RAC 833 E. Rosedale Dr. East Alton, IL (office) (mobile)

April 12, 2018 Session Speakers

Meeting the Challenges: FDA Inspections

Vice President, Regulatory Affairs, Clinical Research, and Quality Assurance AREAS OF EXPERTISE

VENUE. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry in Review , JAN San Diego CA

The Product Journey. An insight into Design, Sterilisation, Testing, Clinical Trial and Accreditation

SPONSORING PACKAGE 3D Medical Printing Conference &Expo. Perugia, Italy 7nd edition July 9 &

GMPs FOR CURRENT TIMES

Digging for 483 Gold: How to Mine FDA's Inspection Reports

CENTER FOR DEVICES AND RADIOLOGICAL HEALTH. Notice to Industry Letters

PROPOSED DOCUMENT. Global Harmonization Task Force. Title: Medical Devices: Post Market Surveillance: Content of Field Safety Notices

Guidance for Industry and FDA Staff Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use

Guidance for Industry

City of Dallas Economic Development Delegation to Beijing and Hong Kong November 11 23, Office of Economic Development

Medical Device Risk Management

The Three Lines of Defense: Risk Management Supervision, Compliance and Internal Audit Monday, May 21 3:00 p.m. 4:00 p.m.

Outreach Seminar for Compliance Professionals: Investment Advisers and Investment Funds. Tuesday 15 July 2014

Services, Inc., an International Freight Forwarder for both Air & Sea freight, NVOCC Container Consolidator & Licensed Customhouse Broker. He has over

Registration of Innovative Medical Devices in China

Current Status and Challenges of Bilateral/Multilateral Meetings

Conflict of Interest and Medical Innovation: Ensuring Integrity while Facilitating Innovation in Medical Research A Workshop

Inspiring Keynote. FDA Presentation. Key Areas. 2nd Annual ComplianceOnline Medical Device Summit 2016

5TH ANNUAL USGBC ENERGY SUMMIT

Breakfast briefing: Ross DeVol Chief Research Officer Milken Institute September 22, 2011 The Phoenix Park Hotel Washington, DC

Study overview. The Global Biomedical Industry: Preserving U.S. Leadership

ANDREW N. TINSETH Assistant Professor of Clinical Accounting

Article 117 A Notified Body perspective, advice on how and when to engage notified bodies

Virtual Clinical Trials: Challenges and Opportunities

TABLE OF CONTENTS DUPONT TYVEK MEDICAL PACKAGING TRANSITION PROJECT (MPTP) EXECUTIVE SUMMARY JUNE 2016 THE FINAL PHASE EXECUTIVE SUMMARY 2

EJ JANIK Principal

ISAAC Conference Our conference rules. It is also called the Conference Code of Conduct

Celebrating International Women's Day Friday, March 8, :30am-1:00pm

Phase 2 of 2009 General Rate Case Witness Qualifications

Biography. Brian E. Klein Century Park East Sixteenth Floor Los Angeles CA t

Truckee Fire Protection District Board of Directors

PDA 71 Years of Connecting People, Science and Regulation

FINAL DOCUMENT. Title: Medical Devices Post Market Surveillance: Content of Field Safety Notices. Endorsed by: The Global Harmonization Task Force

Jean W. Frydman Partner

The Art of the Public Member: Maximizing Your Consumer Member in Public Protection

BREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017

REPORT OF THE SG1 MEETING HELD ON 28/31st MARCH 2006 IN SYDNEY

Jones Day MCLE University

SOUTHERN CALIFORNIA MONITORING ASSOCIATION In God We Trust All Others We Monitor

Presented by the Texas Gulf Coast Chapter. Norris Conference Center Houston/CityCentre Thursday, April 12, :00am-6:00pm

The Association s high-level visit to Hong Kong in April 2018

MINUTES FLORIDA GULF COAST UNIVERSITY BOARD OF TRUSTEES MEETING TUESDAY, JANUARY 18, :30 A.M. STUDENT UNION BALLROOM

Federation of Genealogical Societies. by Carmen J. Finley, Ph.D., CG. Supplemental Page

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

Debra Young, PHR Executive Vice President DHR International, Inc.

HFMA January CFO Forum

ASIFMA Annual Conference 2014

J15 Part A Ask the Contractor Teleconference Call Transcript December 13, 2011 at 2:00p ET Confirmation #

Leasehold Management Service Standards

FDA REGULATION OF DIGITAL HEALTH

CA-NV AWWA METER COMMITTEE

API Standards Overview

PROPERTY ACCOUNTING BREAKOUT Draft Agenda

NPO Solutions, Inc. Corporation

CITY OF LOS ANGELES CALIFORNIA ER!C GARCETTI MAYOR. September 11, 2013

WHO WE SERVE. Regulators Business and Law Schools. Executives and Staff Job Seekers & Students

Time Line of CSSA Firsts

Course Outline and Syllabus for Students

Global Harmonization Task Force

About the Keynote Speaker

The Regents of the University of California. COMMITTEE ON AUDIT March 19, 1998

Environmental Protection Agency

Boeing Long Beach Leadership Association Nominees for the Board of Directors

The UK Science & Innovation Network A Tool for Diplomacy

A Day in the Life of a Science

Revolutionizing Informed Consent: Best Practices that Leverage Innovation and Technology

Annual Report. Better Banking for Everyone

Comprehensive Research Services

Summary of Advocacy Committee Meeting August 10, 2018

Ask the Regulator and Industry Experts Thursday, September 14 3:30 p.m. 4:30 p.m.

Good morning, Director-General Francis Gurry; good morning, everyone. On behalf of the host IP office, I d like to welcome you all to Japan.

September 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board

THE NEW YORK BAR FOUNDATION 2016 The Honorable Judith S. Kaye Commercial and Federal Litigation Scholarship

The 2017 Wisconsin Elevator Symposium Lake Geneva, WI

National space society. Sponsorship opportunities

Scripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011

PROGRAM ANNOUNCEMENT. New Jersey Institute of Technology. MSPhM Systems Engineering. Newark. Fall 2008

ECRA Advisory Council Meeting Minutes of Meeting October 15, 2018

CHAIRMAN & PRESIDENT S REPORT

Welcome to L.A.'s Largest Network of Professional Latinas

Outside Business Activities (OBAs) and Private Securities Transactions (PSTs) Thursday, November 8 1:45 p.m. 2:45 p.m.

the SPD company Dr Clive Simon, Principal, The SPD Company.

CAMD Transition Sub Group FAQ IVDR Transitional provisions

[Definitions of terms that are underlined are found at the end of this document.]

BE THE FUTURE THE WORLD S LEADING EVENT ON AI IN MEDICINE & HEALTHCARE

Combination Products Verification, Validation & Human Factors Sept. 12, 2017

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei

Eligibility Criteria Created Sunday, November 09, 2014

2015 Real Estate Industry Update A landscape for change: Transforming for the future

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D.

The 2018 San Diego Day of Trauma November 2, 2018 Kona Kai Resort Shelter Island San Diego, California. Exhibitor Prospectus

Real World Evidence (RWE): different needs for one goal

ST. JOHNS RIVER STATE COLLEGE DISTRICT BOARD OF TRUSTEES Palatka, Florida. May 20, 2015

CORPORATE ACCOUNTING BREAKOUT Draft Agenda

International Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA

Regulatory Inspections, Examinations, Reviews and Compliance Practices Wednesday, December 2 2:00 p.m. 3:00 p.m.

Transcription:

OCRA Orange County Regulatory Affairs Discussion Group Christine Posin, President June 9, 2008

What is OCRA? Orange County Regulatory Affairs Discussion Group Volunteer organization 501{c}(6) Non-profit organization Mission: Education of regulatory professionals and to provide a neutral forum for the exchange of information. Devices - In Vitro Diagnostics Drugs - Biologics Combination Products

FDA Los Angeles District Serving Southern California & Arizona * Excludes Sound Emitting Devices

California - as compared to the US Almost 20% of medical device manufacturers located in CA Southern California accounts for 25% of all FDA medical product approvals. Biomedical firms employ over 15,000 residents of Orange County. Home to the largest concentration of medical product manufacturers in the world. Produces more biomedical products and research than anywhere in the world. * 1997 data

1992 There was a need for information! Only professional meetings were on the East Coast $$$$ Regulatory professionals started seeking each other out. Started meeting for coffee klatch and lunch discussions.

1992 OCRA Founded Ed Guilmette, Bob Bard Steve Lawrence, Hogan & Hartson Diana Upp Del Stagg, Allergan Brian Donato, Hyman, Phelps, & McNamara

In the beginning Meeting notifications sent by US Mail No internet, limited access to reach out No money to fund programs No staff. Everyone donated time. Kathy Golas, Hogan & Hartson No equipment.

1993 - Organized Ed Guilmette 1 st President Created Board of Directors Perianne Di Rocco Administrator Beginning Activities FDA/FDLI Teleconferences Fullerton College Workshops at Allergan Organized comments to FDA proposed rules

FDA Involvement? Yes! Yes! Yes! In the beginning Elaine Messa, Los Angeles District Director Jim Kozick, Director of Investigations Tom Sawyer, Compliance Director Mark Roh, current acting Regional Director Currently Alonza Cruse, Los Angeles District Director Linda Hartley Katherine Jacobitz Many others participate as speakers

FDA-OCRA Educational Conference 1996 First Co-sponsored conference One day session Presented by Hogan & Hartson FDA, Hogan & Hartson, and OCRA worked together to obtain industry and FDA speakers Goal current topics in regulatory concerns and compliance issues 134 attendees

FDA Activities FDA Open House Speakers for OCRA meetings Support MDR Network group Provide information regarding other conferences and FDA programs in the area.

Hammer Awards Award from Vice-President Al Gore Innovative programs for partnership with the US government better programs/less cost Awarded to LA District FDA and OCRA network groups 1997: Los Angeles Grassroots Regulatory Partnership 1999: MDR Network Group

OCRA Now 16 Years Later Board of Directors 11 members Program Committee Annual Meeting Committee Education & Professional Development Committee 1 paid Administrator

Network Groups No charge to attend meetings. MDR Network Group FDA Liaison appointed to support group Michael Stokke Katherine Jacobitz Support from CDRH Risk Management Network Group Design Control Network Group (DCd)

OCRA Now Over 650 members in 2007; ~100 companies 11 th FDA/OCRA Annual Educational Conference Dr. von Eschenbach Keynote Speaker Expect over 350 attendees 16 FDA speakers, 14 industry speakers Speakers from Japan MHLW and German Competent Authority RAC (Regulatory Affairs Certification) Study Group OCRA Newsletter

OCRA Website www.ocra-dg.org Meeting information Job listing Links to other regulatory organizations Links to area consultants Links to other educational programs Articles of Incorporation, Mission Statement, and By-Laws

2008 Meeting Topics Managing Device Modifications Inspections 101, Warning Letters, and 483s CAPA 101 Regulatory Document Management, Electronic Filings (STED) FDA/OCRA 11 th Annual Educational Conference Tracking and Managing Changes to Standards and Regulations Clinical Trials 101 with Lab including IVDs and International Doing Business in China RAC Exam Study Group (November Exam) MDR Network emdr Complaint Data as Related to CAPA Triggers MDR Case Studies Risk Management Network Group Various topics